SynthesisPloS one2015

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.

Alexandra J van den Broek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.